Skip to main content
. Author manuscript; available in PMC: 2011 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Aug 15;54(5):447–454. doi: 10.1097/QAI.0b013e3181e0c7d0

FIGURE 3. Expression of PD-L1 and of both PD-L1 and PD-1 on monocytes, CD8+ T cells and CD4+ T cells.

FIGURE 3

A. Expression of PD-L1 on monocytes of viremic and aviremic patients and healthy controls; B. Decrease in PD-L1 expression on monocytes at week 48 compared to week 0 in 8 patients followed longitudinally. Expression of PD-L1 on CD4+ T cells (C) and on CD8+ T cells (D) in viremic and aviremic patients and healthy controls. Coexpression of PD-1 and PD-L1 on CD4+ T cells (E) and CD8+ T cells (F); *, P<0.05,**, P<0.01.